Real-World Effectiveness of Perinatal RSV Immunoprophylaxis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Real-World Effectiveness of Perinatal RSV Immunoprophylaxis — Stella

Recruiting

Back to RSV Infection trials

Trial locations(1 site)

United States

Yale Child Health Research Center, New Haven, Connecticut

Key details

Sponsor

Yale University

Collaborators

National Institute of Allergy and Infectious Diseases (NIAID)

Enrollment target

~3,750 participants

Started

October 2024

Primary completion

December 2028

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov